Evidence map›Paper›PMID 10357931›Full record

ArticleDevelopment (Cambridge, England)1999

POU domain factor Brn-3a controls the differentiation and survival of trigeminal neurons by regulating Trk receptor expression.

E J Huang, K Zang, A Schmidt, A Saulys, M Xiang, L F Reichardt

Open access · greenAbstract read
In one paragraph

Article in Development (Cambridge, England), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 124 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Biphasic functions for the GDNF-Ret signaling pathway in chemosensory neuron development and diversification.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Bex3 Dimerization Regulates NGF-Dependent Neuronal Survival and Differentiation by Enhancing trkA Gene Transcription.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  17. Article
  18. Article
  19. Protein tyrosine phosphatase receptor type O inhibits trigeminal axon growth and branching by repressing TrkB and Ret signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E J HuangProgram in Neuroscience, Department of Physiology, and Howard Hughes Medical Institute, University of California, San Francisco, CA 94143-0723. USA.
K Zang
A Schmidt
A Saulys
M Xiang
L F Reichardt
Howard Hughes Medical Institute · US

Funding

VESICULAR NEUROTRANSMITTER STORAGE/TRANSPORT IN SYNAPSE FUNCTION AND DEVELOPMENTP01NS016033 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI REICHARDT, LOUIS FRENCH · 1985 to 2007
$7.5M
Transcriptional Regulation of Retinal DevelopmentR01EY012020 · NEI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI XIANG, MENGQING · 1998 to 2012
$3.7M
NEI NIH HHS R01 EY012020NEI NIH HHS R01 EY12020NIMH NIH HHS MH482000NINDS NIH HHS P01 NS016033
6 · The paper itself

Abstract

Mice lacking the POU domain-containing transcription factor Brn-3a have several neuronal deficits. In the present paper, we show that Brn-3a plays two distinct roles during development of the trigeminal ganglion. In this ganglion, neurons expressing the neurotrophin receptors, TrkB and TrkC, are born between E9.5 and E11.5. In the absence of Brn-3a, very few neurons ever express TrkC, but TrkB-expressing neurons are present at E12.5 in elevated numbers, suggesting that Brn-3a may be a constituent of a regulatory circuit determining which Trk receptor is expressed by these early-born neurons. Most neurons expressing the neurotrophin receptor TrkA are generated between E11.5 and E13.5 in this ganglion and their initial generation is not prevented by absence of Brn-3a. However, after E12. 5, absence of Brn-3a results in a progressive loss in neuronal TrkA and TrkB expression, which leads to a massive wave of apoptosis that peaks at E15.5. Despite complete absence of the Trk receptors at E17. 5 and P0, approximately 30% of the normal complement of neurons survive to birth in Brn-3a mutants. Approximately 70% of these express the GDNF receptor subunit, c-ret; many can be sustained by GDNF, but not by NGF in culture. Thus, the vast majority of surviving neurons are probably sustained in vivo by trophic factor(s) whose receptors are not regulated by Brn-3a. In conclusion, our data indicate the specific functions of Brn-3a in controlling the survival and differentiation of trigeminal neurons by regulating expression of each of the three Trk receptors.

Indexed as

Drosophila ProteinsNerve Growth FactorsAnimalsApoptosisCell CountCell DifferentiationCells, CulturedCell SurvivalDNA-Binding ProteinsGene Expression Regulation, DevelopmentalGlial Cell Line-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic Factor ReceptorsImmunohistochemistryMiceMice, KnockoutNerve Tissue ProteinsDNA-Binding ProteinsDrosophila ProteinsGdnf protein, mouseGlial Cell Line-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic Factor ReceptorsNerve Growth FactorsNerve Tissue ProteinsParvalbuminsPou4f1 protein, mouseProto-Oncogene ProteinsProto-Oncogene Proteins c-retReceptor, Ciliary Neurotrophic FactorReceptor, Nerve Growth FactorReceptor Protein-Tyrosine KinasesReceptors, Nerve Growth FactorReceptor, trkAReceptor, trkCRet protein, DrosophilaRet protein, mouseTranscription Factor Brn-3Transcription Factor Brn-3ATranscription Factors

Identifiers

PMID10357931
PMCPMC2710123
OpenAlexW2138066183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.